Labcorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes ...

Healthcare diagnostics company Labcorp Holdings (NYSE:LH) in Q3 CY2025, with sales up 8.6% year on year to $3.56 billion. Its ...

BURLINGTON, N.C. (WTVD) -- North Carolina-based LabCorp has received emergency use authorization from the Food and Drug Administration for a COVID-19 At-Home Test Kit. The kit allows for patients to ...

Stinging Insect Component Testing Combined with Interpretative Report Offers Enhanced Patient Management “Labcorp is the only reference laboratory to offer stinging insect (venom) component testing,” ...

A Labcorp team member draws blood from a patient.Labcorp Labcorp, one of the country’s largest providers of diagnostic ...

BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced the launch of the first widely accessible test that provides direct evidence of ...

BURLINGTON – A new test developed by Labcorp can help people find treatment options for skin cancer. The test, which Labcorp announced in a statement, is available for use in clinical trials and for ...

BURLINGTON – Labcorp has opened a new testing program for cancer patients, sponsored by Eli Lilly and Company, which is also expanding its operations and footprint in North Carolina with a new ...

Labcorp delivered mixed third-quarter results, with higher sales and raised profit | Labcorp reported solid third-quarter ...

Labcorp on Tuesday raised its annual profit forecast and beat estimates in the third quarter as the laboratory operator ...

BURLINGTON, N.C.--(BUSINESS WIRE)--Nearly 10 million people in the United States have a history of systemic or anaphylactic reaction to insect stings, with the risk of a severe and potentially ...